COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1980.9 | 6 | 0307-0537 | 520.57 | 536.09 | 307 | 66.18 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2883.4 | 6 | 0308-0540 | 795.24 | 540.18 | 237 | 62.77 | 0.756 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2028.7 | 6 | 0309-0541 | 927.11 | 540.64 | 263 | 61.36 | 0.878 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1498.3 | 6 | 0310-0541 | 111.28 | 540.83 | 251 | 61.94 | 0.822 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 510.3 | 6 | 0311-0538 | 356.39 | 538.08 | 144 | 45.36 | 0.880 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1814.5 | 6 | 0312-0542 | 430.57 | 542.86 | 238 | 62.43 | 0.767 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1388.9 | 6 | 0313-0544 | 37.62 | 545.15 | 245 | 60.18 | 0.850 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1191.1 | 6 | 0314-0547 | 665.59 | 548.67 | 353 | 72.67 | 0.840 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 4085.8 | 6 | 0315-0546 | 456.52 | 545.84 | 221 | 57.36 | 0.844 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 410.2 | 6 | 0316-0549 | 376.55 | 548.79 | 276 | 62.87 | 0.877 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1282.7 | 6 | 0317-0551 | 228.15 | 552.09 | 280 | 66.77 | 0.789 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1036.4 | 6 | 0318-0547 | 558.15 | 547.60 | 267 | 61.94 | 0.875 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1705.3 | 6 | 0319-0549 | 84.88 | 549.15 | 205 | 52.28 | 0.942 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 727.4 | 6 | 0320-0548 | 343.66 | 548.44 | 170 | 50.18 | 0.848 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2003.5 | 6 | 0321-0550 | 623.33 | 550.48 | 234 | 56.77 | 0.912 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2002.7 | 6 | 0322-0553 | 852.44 | 553.40 | 224 | 58.53 | 0.822 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1983.4 | 6 | 0323-0552 | 702.41 | 551.60 | 300 | 63.36 | 0.939 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1836.2 | 6 | 0324-0555 | 65.46 | 554.14 | 214 | 59.70 | 0.755 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 5286.5 | 6 | 0325-0559 | 412.48 | 559.15 | 240 | 58.18 | 0.891 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 4646.5 | 6 | 0326-0556 | 466.53 | 556.84 | 195 | 54.53 | 0.824 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2138.5 | 6 | 0327-0560 | 785.46 | 559.58 | 267 | 62.43 | 0.861 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 345.6 | 6 | 0328-0560 | 950.45 | 560.92 | 238 | 60.53 | 0.816 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 353.7 | 6 | 0329-0566 | 215.30 | 565.75 | 257 | 61.70 | 0.848 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2121.5 | 6 | 0330-0569 | 328.41 | 568.40 | 269 | 61.60 | 0.891 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1487.8 | 6 | 0331-0574 | 461.56 | 575.67 | 264 | 67.36 | 0.731 |